These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 12604705

  • 1. Active transport of high-affinity choline and nicotine analogs into the central nervous system by the blood-brain barrier choline transporter.
    Allen DD, Lockman PR, Roder KE, Dwoskin LP, Crooks PA.
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1268-74. PubMed ID: 12604705
    [Abstract] [Full Text] [Related]

  • 2. Carrier-mediated transport of the quaternary ammonium neuronal nicotinic receptor antagonist n,n'-dodecylbispicolinium dibromide at the blood-brain barrier.
    Lockman PR, Manda VK, Geldenhuys WJ, Mittapalli RK, Thomas F, Albayati ZF, Crooks PA, Dwoskin LP, Allen DD.
    J Pharmacol Exp Ther; 2008 Jan; 324(1):244-50. PubMed ID: 17921191
    [Abstract] [Full Text] [Related]

  • 3. 3D-QSAR study of bis-azaaromatic quaternary ammonium analogs at the blood-brain barrier choline transporter.
    Geldenhuys WJ, Lockman PR, Nguyen TH, Van der Schyf CJ, Crooks PA, Dwoskin LP, Allen DD.
    Bioorg Med Chem; 2005 Jul 01; 13(13):4253-61. PubMed ID: 15878282
    [Abstract] [Full Text] [Related]

  • 4. Molecular modeling studies on the active binding site of the blood-brain barrier choline transporter.
    Geldenhuys WJ, Lockman PR, McAfee JH, Fitzpatrick KT, Van der Schyf CJ, Allen DD.
    Bioorg Med Chem Lett; 2004 Jun 21; 14(12):3085-92. PubMed ID: 15149650
    [Abstract] [Full Text] [Related]

  • 5. N-n-alkylpyridinium analogs, a novel class of nicotinic receptor antagonists: selective inhibition of nicotine-evoked [3H] dopamine overflow from superfused rat striatal slices.
    Grinevich VP, Crooks PA, Sumithran SP, Haubner AJ, Ayers JT, Dwoskin LP.
    J Pharmacol Exp Ther; 2003 Sep 21; 306(3):1011-20. PubMed ID: 12766255
    [Abstract] [Full Text] [Related]

  • 6. N-n-alkylnicotinium analogs, a novel class of nicotinic receptor antagonist: inhibition of S(-)-nicotine-evoked [(3)H]dopamine overflow from superfused rat striatal slices.
    Wilkins LH, Haubner A, Ayers JT, Crooks PA, Dwoskin LP.
    J Pharmacol Exp Ther; 2002 Jun 21; 301(3):1088-96. PubMed ID: 12023541
    [Abstract] [Full Text] [Related]

  • 7. Introduction of unsaturation into the N-n-alkyl chain of the nicotinic receptor antagonists, NONI and NDNI: effect on affinity and selectivity.
    Sumithran SP, Crooks PA, Xu R, Zhu J, Deaciuc AG, Wilkins LH, Dwoskin LP.
    AAPS J; 2005 Aug 29; 7(1):E201-17. PubMed ID: 16146341
    [Abstract] [Full Text] [Related]

  • 8. Development of subtype-selective ligands as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release.
    Crooks PA, Ayers JT, Xu R, Sumithran SP, Grinevich VP, Wilkins LH, Deaciuc AG, Allen DD, Dwoskin LP.
    Bioorg Med Chem Lett; 2004 Apr 19; 14(8):1869-74. PubMed ID: 15050618
    [Abstract] [Full Text] [Related]

  • 9. Reduced expression and capacity of the striatal high-affinity choline transporter in hyperdopaminergic mice.
    Parikh V, Apparsundaram S, Kozak R, Richards JB, Sarter M.
    Neuroscience; 2006 Aug 11; 141(1):379-89. PubMed ID: 16675138
    [Abstract] [Full Text] [Related]

  • 10. Chronic nicotine exposure alters blood-brain barrier permeability and diminishes brain uptake of methyllycaconitine.
    Lockman PR, Van der Schyf CJ, Abbruscato TJ, Allen DD.
    J Neurochem; 2005 Jul 11; 94(1):37-44. PubMed ID: 15953347
    [Abstract] [Full Text] [Related]

  • 11. P-glycoprotein does not actively transport nicotine and cotinine.
    Wang JS, Markowitz JS, Donovan JL, Devane CL.
    Addict Biol; 2005 Jun 11; 10(2):127-9. PubMed ID: 16191663
    [Abstract] [Full Text] [Related]

  • 12. Interactions of nucleoside analogs, caffeine, and nicotine with human concentrative nucleoside transporters 1 and 2 stably produced in a transport-defective human cell line.
    Lang TT, Young JD, Cass CE.
    Mol Pharmacol; 2004 Apr 11; 65(4):925-33. PubMed ID: 15044622
    [Abstract] [Full Text] [Related]

  • 13. The blood-brain barrier transport and cerebral distribution of guanidinoacetate in rats: involvement of creatine and taurine transporters.
    Tachikawa M, Kasai Y, Yokoyama R, Fujinawa J, Ganapathy V, Terasaki T, Hosoya K.
    J Neurochem; 2009 Oct 11; 111(2):499-509. PubMed ID: 19682207
    [Abstract] [Full Text] [Related]

  • 14. GHB (gamma-hydroxybutyrate) carrier-mediated transport across the blood-brain barrier.
    Bhattacharya I, Boje KM.
    J Pharmacol Exp Ther; 2004 Oct 11; 311(1):92-8. PubMed ID: 15173314
    [Abstract] [Full Text] [Related]

  • 15. Cloned blood-brain barrier adenosine transporter is identical to the rat concentrative Na+ nucleoside cotransporter CNT2.
    Li JY, Boado RJ, Pardridge WM.
    J Cereb Blood Flow Metab; 2001 Aug 11; 21(8):929-36. PubMed ID: 11487728
    [Abstract] [Full Text] [Related]

  • 16. The brain-to-blood efflux transport of taurine and changes in the blood-brain barrier transport system by tumor necrosis factor-alpha.
    Lee NY, Kang YS.
    Brain Res; 2004 Oct 08; 1023(1):141-7. PubMed ID: 15364029
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the effects of bupropion on nicotinic receptor-evoked [(3)H]dopamine release from rat striatal synaptosomes and slices.
    Sidhpura N, Redfern P, Wonnacott S.
    Eur J Pharmacol; 2007 Jul 12; 567(1-2):102-9. PubMed ID: 17477919
    [Abstract] [Full Text] [Related]

  • 18. Regulation of blood-brain barrier Na,K,2Cl-cotransporter through phosphorylation during in vitro stroke conditions and nicotine exposure.
    Abbruscato TJ, Lopez SP, Roder K, Paulson JR.
    J Pharmacol Exp Ther; 2004 Aug 12; 310(2):459-68. PubMed ID: 15051802
    [Abstract] [Full Text] [Related]

  • 19. The blood-brain barrier sodium-dependent multivitamin transporter: a molecular functional in vitro-in situ correlation.
    Park S, Sinko PJ.
    Drug Metab Dispos; 2005 Oct 12; 33(10):1547-54. PubMed ID: 16033951
    [Abstract] [Full Text] [Related]

  • 20. Involvement of the pyrilamine transporter, a putative organic cation transporter, in blood-brain barrier transport of oxycodone.
    Okura T, Hattori A, Takano Y, Sato T, Hammarlund-Udenaes M, Terasaki T, Deguchi Y.
    Drug Metab Dispos; 2008 Oct 12; 36(10):2005-13. PubMed ID: 18606742
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.